These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 29843224

  • 1. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM, Mohammed Saleh MF, Sayed MM, Rayan A, Ali AM, Hetta HF.
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [Abstract] [Full Text] [Related]

  • 2. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C, Chen X, Yu X, Zhu Y, Ma C, Xia R, Ma J, Gu C, Ye L, Wu D.
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [Abstract] [Full Text] [Related]

  • 3. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE, Ravandi F, Jabbour EJ, Al-Hamal Z, Konopleva M, Ning J, Xiao L, Hidalgo Lopez J, Kornblau SM, Andreeff M, Flores W, Bueso-Ramos C, Blando J, Galera P, Calvo KR, Al-Atrash G, Allison JP, Kantarjian HM, Sharma P, Daver NG.
    Cancer; 2019 May 01; 125(9):1470-1481. PubMed ID: 30500073
    [Abstract] [Full Text] [Related]

  • 4. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M, Zhang C, Tian T, Zhang T, Wang R, Han F, Zhong C, Hua M, Ma D.
    Front Immunol; 2018 May 01; 9():1274. PubMed ID: 29922294
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
    Wan Y, Zhang C, Xu Y, Wang M, Rao Q, Xing H, Tian Z, Tang K, Mi Y, Wang Y, Wang J.
    BMC Cancer; 2020 May 26; 20(1):472. PubMed ID: 32456622
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Delia M, Carluccio P, Mestice A, Frappampina R, Albano F, Specchia G, Musto P.
    J Immunol Res; 2020 May 26; 2020():2134647. PubMed ID: 33204734
    [Abstract] [Full Text] [Related]

  • 9. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells.
    Vaughan JW, Shi M, Horna P, Olteanu H.
    Ann Diagn Pathol; 2020 Oct 26; 48():151585. PubMed ID: 32829067
    [Abstract] [Full Text] [Related]

  • 10. Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center.
    Tiribelli M, Michelutti A, Cavallin M, Di Giusto S, Fanin R, Damiani D.
    Turk J Haematol; 2021 Jun 01; 38(2):119-125. PubMed ID: 33596632
    [Abstract] [Full Text] [Related]

  • 11. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH, Sudha T, Godugu K, Elbaz O, Abdelghaffar HA, Hassan EE, Mousa SA.
    Oncotarget; 2016 Sep 06; 7(36):57811-57820. PubMed ID: 27506934
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
    Tiribelli M, Raspadori D, Geromin A, Cavallin M, Sirianni S, Simeone E, Bocchia M, Fanin R, Damiani D.
    Leuk Res; 2017 Jul 06; 58():31-38. PubMed ID: 28407515
    [Abstract] [Full Text] [Related]

  • 15. Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance.
    Xiang M, Guo L, Ma Y, Li Y.
    Pak J Pharm Sci; 2016 Nov 06; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [Abstract] [Full Text] [Related]

  • 16. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S, Liang C, Zhao Y, Deng T, Tan J, Zha X, Li Y, Chen S.
    Cytometry B Clin Cytom; 2022 Mar 06; 102(2):143-152. PubMed ID: 34913594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
    Tiribelli M, Geromin A, Cavallin M, Di Giusto S, Simeone E, Fanin R, Damiani D.
    Eur J Haematol; 2017 Sep 06; 99(3):269-274. PubMed ID: 28618016
    [Abstract] [Full Text] [Related]

  • 19. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
    Damiani D, Tiribelli M, Raspadori D, Sirianni S, Meneghel A, Cavalllin M, Michelutti A, Toffoletti E, Geromin A, Simeone E, Bocchia M, Fanin R.
    Oncotarget; 2015 Oct 06; 6(30):30212-21. PubMed ID: 26338961
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.